4.09 Problems with the VISION Trial & Stool Transplant Plus Nivo for Metastatic Melanoma

Plenary Session

English - July 23, 2021 19:18 - 26 minutes - 22.1 MB - ★★★★★ - 722 ratings
Science Health & Fitness Medicine medicine oncology health policy Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: 4.08 Implications for the Fate of Accelerated Approval from the ODAC Votes of April 2021

Next Episode: 4.10 A Deep Dive into CheckMate 649 with Dr. Jeffrey Bien

Today we have two short monologues for you on recent papers. The first, by popular request, is the problems with the VISION trial, which treated metastatic castration-resistant prostate cancer with lutetium-177–PSMA-617 (Lu-177–PSMA-617) radioligand therapy and standard of care. The second is on the paper recently published in Science titled "Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients".

Fecal transplant: doi.org/10.1126/science.abb5920

Back us on Patreon! www.patreon.com/plenarysession

Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew